However, for setting up SOX11, INSM1, and MEOX2 assays, tissues with the strongest expression were chosen, given the lack of weak expressing tissues and general need to identify strong expressing cells of mantle cell lymphoma (SOX11), neuroendocrine tumours (INSM1), and endothelium (MEOX2). This evidence concerns the gene INSM1 and mantle cell lymphoma.